Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal


Suchbegriffe: TUMOR SUPPRESSOR PROTEIN P53 - GENETICS , . Treffer: 15


Kashofer, K; Regauer, S Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
GYNECOL ONCOL. 2017; 146(2): 314-318.
Web of Science PubMed FullText FullText_MUG


Lax, SF Pathology of Endometrial Carcinoma.
Adv Exp Med Biol. 2017; 943(4):75-96
Web of Science PubMed FullText FullText_MUG



Leithner, K; Hrzenjak, A; Trötzmüller, M; Moustafa, T; Köfeler, HC; Wohlkoenig, C; Stacher, E; Lindenmann, J; Harris, AL; Olschewski, A; Olschewski, H PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.
Oncogene. 2015; 34(8):1044-1050
Web of Science PubMed FullText FullText_MUG



Morisaki, T; Müller, WG; Golob, N; Mazza, D; McNally, JG Single-molecule analysis of transcription factor binding at transcription sites in live cells.
NAT COMMUN. 2014; 5: 4456-4456. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Gottschalk, B; Klein, A Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype.
Mol Cell Biochem. 2013; 379(1-2):213-227
Web of Science PubMed FullText FullText_MUG


Houben, R; Dreher, C; Angermeyer, S; Borst, A; Utikal, J; Haferkamp, S; Peitsch, WK; Schrama, D; Hesbacher, S Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
J Invest Dermatol. 2013; 133(10):2453-2460 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Schupp, M; Chen, F; Briggs, ER; Rao, S; Pelzmann, HJ; Pessentheiner, AR; Bogner-Strauss, JG; Lazar, MA; Baldwin, D; Prokesch, A Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues.
BMC Genomics. 2013; 14(11):758-758 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wölfler, A; Zebisch, A; Olipitz, W; Geigl, J; Berghold, A; Speicher, MR; Sill, H Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
J Med Genet. 2012; 49(7):422-428
Web of Science PubMed FullText FullText_MUG


Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012; 287(9):755-764
Web of Science PubMed FullText FullText_MUG



Langner, C Non-serrated precursor lesions of colorectal tumours.
Pathologe. 2011; 32 Suppl 2(1):206-210
PubMed FullText FullText_MUG


Morselli, E; Shen, S; Ruckenstuhl, C; Bauer, MA; Mariño, G; Galluzzi, L; Criollo, A; Michaud, M; Maiuri, MC; Chano, T; Madeo, F; Kroemer, G p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200.
Cell Cycle. 2011; 10(16):2763-2769 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Bohlig, L; Metzger, R; Rother, K; Till, H; Engeland, K The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor
Cell Cycle. 2008; 7(9):1254-1261 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Goel, A; Fuerst, F; Hotchkiss, E; Boland, CR Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Cancer Biol Ther. 2006; 5(5):529-535 [OPEN ACCESS]
Web of Science PubMed



Seidl, H; Kreimer-Erlacher, H; Bäck, B; Soyer, HP; Höfler, G; Kerl, H; Wolf, P Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
J Invest Dermatol. 2001; 117(2):365-370 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar



Egle, A; Villunger, A; Marschitz, I; Kos, M; Hittmair, A; Lukas, P; Grünewald, K; Greil, R Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Br J Haematol. 1997; 97(2): 418-428.
Web of Science PubMed


© Meduni Graz Impressum